Massachusetts Institute of Technology: Innovative Chip Could Lower Costs in Cancer Therapy Cell…
Researchers from the Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, have developed a novel way to produce clinical doses of viable autologous chimeric antigen receptor (CAR) T-cells…